生物製剤用皮下注射装置市場

当レポートでは、生物製剤用皮下注射装置市場について調査し、市場の概要とともに、市場の機会、製品概要、規制の問題、競合情勢、および市場に参入する企業のプロファイルなどを提供しています。

目次

• エグゼクティブサマリー
• 市場の機会
• デリバリー市場力学
• 注射薬の経済学
• 注射装置の成長を推進しているのは何か
• プレフィルドシリンジの普及
• 自己投与型への傾倒
• 人口動態の変化
• ディスポーザブル装置設計の革新
• 生物製剤の普及
• 治療用モノクローナル抗体
• 治療需要の促進要因
• 競合情勢
• 危険因子
• 自動注射器-商用装置
• 手動注射自動注射器
• 自動注射自動注射器
• 使い捨てオートインジェクター
• ワイヤレス対応のオートインジェクター
• オートインジェクターの設計要素
• 材料選択の問題
• 部品点数と装置コスト
• 安全機能
• 針挿入深さ
• フェイルセーフアクティベーション
• 用量検査/注射の確認
• 凍結乾燥薬/再構成
• 人間工学/エルゴノミクス
• ペンインジェクター
• ペンインジェクターの設計選択要因
• 標準化されたペンプラットフォーム
• カスタムペンデザイン
• 再利用ペン
• デュアルチャンバーペン
• 市販のペン製品
• ワイヤレスデータ
• 主要な治療セクター分析
• アナフィラキシー/対策
• 自己免疫疾患
• 関節リウマチ
• 乾癬
• 多発性硬化症
• 肝炎
• ホルモン
• 骨粗鬆症
• 市場要因
• 規制の問題
• 装置のブランディング
• 患者のアドヒアランスと使いやすさ
• ヘルスケア経済学
• 企業プロファイル

For drug self-administration devices, human engineering and user ergonomics are essential attributes that impact critical patient issues such as safety and patient compliance. While designers have acquired many powerful design tools during the past decade - tools that include 3D CAD design software and high-performance materials, design team have been increasingly relying on classic end user research to define the design targets for their projects. For drug self-administration devices, human engineering and user ergonomics are essential attributes that impact critical patient issues such as safety and patient compliance. While designers have acquired many powerful design tools during the past decade - tools that include 3D CAD design software and high-performance materials, design team have been increasingly relying on classic end user research to define the design targets for their projects.

What You Will Learn:

• Provides detailed analysis of subcutaneous drug products, drug delivery and device strategies, and product development factors

• Assesses key markets, market dynamics and market demographics

• Analyzes therapeutic demand drivers and evaluates SC drug products in nine key therapeutic segments

• Provides market data and forecasts to 2028

• Profiles market sector participants, their product development activities, business strategies, and corporate alliances and affiliations

• Assesses the importance of alliances and partnerships on subcutaneous drug product commercialization

• Evaluates the impact of economic, technology, and regulatory factor

Table of Contents

• Executive Summary
• The Market Opportunity
• Delivery Market Dynamics
• The Economics of Injectable Drugs
• What's Driving the Growth in Injectable Devices?
• Prefilled Syringes Proliferating
• The Trend toward Self-Administration
• Shifting Demographics
• Innovation in Disposable Device Designs
• Proliferation of Biological Drugs
• Therapeutic Monoclonal Antibodies
• Therapeutic Demand Drivers
• Competitive Landscape
• Risk Factors
• Autoinjectors - Commercial Devices
• Manual Injection Autoinjectors
• Automated Injection Autoinjectors
• Disposable Autoinjectors
• AutoJect 2 (Owen Mumford)
• SelfDose (West Pharmaceutical Services)
• Flexi-Q PFS (Elcam Medical)
• OTS Autoinjector (Consort Medical)
• Pro-Ject (Aptar)
• Consort Medical ASI
• Ypsomed VarioJect
• Rotaject Technology (SHL Medical)
• Viscala Autoinjector (Consort Medical)
• Flexi-Q HV (Elcam Medical)
• Intevia (Becton Dickinson)
• Antares Pharma Autoinjectors
• Dali Medical Devices
• Development-stage Autoinjectors
• NIS Autoinjector (Midas Pharma)
• ArQ - Bios (Oval Medical)
• Wirelessly Enabled Autoinjectors
• BETACONNECT (Bayer)
• RebiSmart (Merck Serono)
• Autoinjector Device Design Factors
• Material Selection Issues
• Part Counts and Device Cost
• Safety Features
• Needle Insertion Depth
• Failsafe Activation
• Dose Inspection/Injection Confirmation
• Lyophilized Drugs/Reconstitution
• Human Engineering/Ergonomics
• Pen Injectors
• Pen Injector Design Selection Factors
• Standardized Pen Platforms
• Haselmeier
• Becton Dickinson
• Owen Mumford
• Autoject2
• Ypsomed
• SHL Medical
• Custom Pen Designs
• Reusable Pens
• Dual Chamber Pens
• Commercial Pen Products
• Genotropin Pen
• Humatro-Pen/Humatro Pen 3
• Norditropin
• Wearable Devices - Product Analysis and Assessments
• Libertas (Becton Dickinson)
• Patch Pump (Sensile Medical)
• SmartDose (West Pharmaceuticals)
• Neulasta OnPro Injector (Insulet/Amgen)
• YpsoDose (Ypsomed)
• Electronic Semi-disposable
• E3D Patch Pump (Elcam)
• Mechanical Disposable
• enFuse (Enable Injections)
• Captive Devices
• sc2Wear Infusor (scPharmaceuticals)
• PatchPump (SteadyMed)
• Wireless Data
• Key Therapeutic Sector Analysis
• Anaphylaxis/Countermeasures
• Autoimmune Diseases
• Rheumatoid Arthritis
• Psoriasis
• Multiple Sclerosis
• Exenatide (Byetta)
• Bydureon
• Pramlinitide (Symlin)
• Abliglutide (Tanzeum)
• Hepatitis
• Hormones
• Osteoporosis
• Market Factors
• Regulatory Issues
• Device Branding
• Patient Adherence and Ease of Use
• Healthcare Economics
• Company Profiles